1. Home
  2. AWH vs OMH Comparison

AWH vs OMH Comparison

Compare AWH & OMH Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • AWH
  • OMH
  • Stock Information
  • Founded
  • AWH 1993
  • OMH 2015
  • Country
  • AWH United States
  • OMH Singapore
  • Employees
  • AWH N/A
  • OMH N/A
  • Industry
  • AWH Medical/Dental Instruments
  • OMH Real Estate
  • Sector
  • AWH Health Care
  • OMH Finance
  • Exchange
  • AWH Nasdaq
  • OMH Nasdaq
  • Market Cap
  • AWH 10.5M
  • OMH 9.1M
  • IPO Year
  • AWH N/A
  • OMH 2023
  • Fundamental
  • Price
  • AWH $0.50
  • OMH $0.34
  • Analyst Decision
  • AWH Buy
  • OMH Strong Buy
  • Analyst Count
  • AWH 2
  • OMH 1
  • Target Price
  • AWH $4.40
  • OMH $1.50
  • AVG Volume (30 Days)
  • AWH 100.3K
  • OMH 240.8K
  • Earning Date
  • AWH 11-14-2024
  • OMH 09-25-2024
  • Dividend Yield
  • AWH N/A
  • OMH N/A
  • EPS Growth
  • AWH N/A
  • OMH N/A
  • EPS
  • AWH N/A
  • OMH N/A
  • Revenue
  • AWH $8,963,000.00
  • OMH $5,390,607.00
  • Revenue This Year
  • AWH $11.87
  • OMH $101.90
  • Revenue Next Year
  • AWH $79.10
  • OMH $38.34
  • P/E Ratio
  • AWH N/A
  • OMH N/A
  • Revenue Growth
  • AWH N/A
  • OMH 25.77
  • 52 Week Low
  • AWH $0.38
  • OMH $0.32
  • 52 Week High
  • AWH $5.65
  • OMH $6.00
  • Technical
  • Relative Strength Index (RSI)
  • AWH 27.14
  • OMH 41.08
  • Support Level
  • AWH $0.38
  • OMH $0.40
  • Resistance Level
  • AWH $0.79
  • OMH $0.45
  • Average True Range (ATR)
  • AWH 0.07
  • OMH 0.04
  • MACD
  • AWH -0.02
  • OMH -0.01
  • Stochastic Oscillator
  • AWH 27.91
  • OMH 10.53

About AWH Aspira Women's Health Inc.

Aspira Womens Health Inc is engaged in developing and commercializing diagnostic tests for gynecologic diseases. Its products include OvaSuite which is a portfolio of blood tests that applies proprietary algorithms incorporating patient features; OvaWatch intended for use in assessing the risk of ovarian cancer for women with adnexal masses; and Ova1Plus is a portfolio of blood tests, Ova1Plus is a combination of two FDA-cleared tests for women with pelvic masses who are planned for surgery.

About OMH Ohmyhome Limited

Ohmyhome Ltd is a data and technology-driven property technology company based in Singapore. Through its subsidiaries, it operates a one-stop-shop property platform that provides end-to-end property solutions and services for its customers, which comprises brokerage services and emerging and other services, such as home renovation and furnishing services, listing and research, mortgage referral, legal services, and insurance referral services. The company derives its revenues from two sources: revenue from brokerage services, Property Management Services, and revenue from emerging and other services.

Share on Social Networks: